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Abstract
© 2016, Springer Science+Business Media New York.Current cancer treatments still  remain
ineffective and cause side effects which ruinously affect healthy cells. Among new promising
anticancer drugs, special attention is paid to the ribonucleases (RNases) which possess selective
cytotoxicity against malignant cells. It is found that besides enzymatic activity conformational
state of RNase molecules plays a role in the anticancer activity. Balnase, a new RNase from
Bacillus altitudinis, is a close homolog of Bacillus pumilus RNase (binase) which selectively kills
malignant cells  expressing oncogenes KIT,  ras,  AML1/ETO, and FLT3.  Earlier,  homogeneous
sample  of  balnase  was  obtained.  Here,  we  have  characterized  structural  organization  of
balnase. It was shown that it is a natural dimer. The enzyme has the same conformational state
as binase but balnase dimers are less stable.
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